Tracking the Trends in the Adoption of Reliever-Only ICS-Formoterol Therapy and SMART

Sandra E. Zaeh; James G. Krings

doi:10.1016/j.jaip.2023.05.038

Tracking the Trends in the Adoption of Reliever-Only ICS-Formoterol Therapy and SMART

Research output: Contribution to journal › Editorial

Original language	English
Pages (from-to)	2765-2766
Number of pages	2
Journal	Journal of Allergy and Clinical Immunology: In Practice
Volume	11
Issue number	9
DOIs	https://doi.org/10.1016/j.jaip.2023.05.038
State	Published - Sep 2023

Access to Document

10.1016/j.jaip.2023.05.038

Cite this

@article{59586cffb08f4581a2ef5601874ebd65,

title = "Tracking the Trends in the Adoption of Reliever-Only ICS-Formoterol Therapy and SMART",

author = "Zaeh, {Sandra E.} and Krings, {James G.}",

note = "Funding Information: Conflicts of interest: S. E. Zaeh has received consulting feeds from AstraZeneca. J. G. Krings receives funding from the National Institutes of Health (NIH) and the American Lung Association (ALA); and has received consulting fees from Genentech and SanofiSanofi/Regeneron. Funding Information: Conflicts of interest: S. E. Zaeh has received consulting feeds from AstraZeneca. J. G. Krings receives funding from the National Institutes of Health (NIH) and the American Lung Association (ALA); and has received consulting fees from Genentech and Sanofi Sanofi / Regeneron . ",

year = "2023",

month = sep,

doi = "10.1016/j.jaip.2023.05.038",

language = "English",

volume = "11",

pages = "2765--2766",

journal = "Journal of Allergy and Clinical Immunology: In Practice",

issn = "2213-2198",

number = "9",

}

TY - JOUR

T1 - Tracking the Trends in the Adoption of Reliever-Only ICS-Formoterol Therapy and SMART

AU - Zaeh, Sandra E.

AU - Krings, James G.

N1 - Funding Information: Conflicts of interest: S. E. Zaeh has received consulting feeds from AstraZeneca. J. G. Krings receives funding from the National Institutes of Health (NIH) and the American Lung Association (ALA); and has received consulting fees from Genentech and SanofiSanofi/Regeneron. Funding Information: Conflicts of interest: S. E. Zaeh has received consulting feeds from AstraZeneca. J. G. Krings receives funding from the National Institutes of Health (NIH) and the American Lung Association (ALA); and has received consulting fees from Genentech and Sanofi Sanofi / Regeneron .

PY - 2023/9

Y1 - 2023/9

UR - http://www.scopus.com/inward/record.url?scp=85169512366&partnerID=8YFLogxK

U2 - 10.1016/j.jaip.2023.05.038

DO - 10.1016/j.jaip.2023.05.038

M3 - Editorial

C2 - 37684074

AN - SCOPUS:85169512366

SN - 2213-2198

VL - 11

SP - 2765

EP - 2766

JO - Journal of Allergy and Clinical Immunology: In Practice

JF - Journal of Allergy and Clinical Immunology: In Practice

IS - 9

ER -

Tracking the Trends in the Adoption of Reliever-Only ICS-Formoterol Therapy and SMART

Access to Document

Other files and links

Cite this